Raiffeisen Bank International AG Raises Position in Synopsys, Inc. $SNPS

Raiffeisen Bank International AG raised its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 5.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 16,658 shares of the semiconductor company’s stock after buying an additional 926 shares during the quarter. Raiffeisen Bank International AG’s holdings in Synopsys were worth $8,118,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the business. Independence Bank of Kentucky boosted its position in shares of Synopsys by 120.0% during the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock valued at $28,000 after acquiring an additional 30 shares during the last quarter. Saudi Central Bank purchased a new stake in Synopsys in the first quarter valued at approximately $26,000. Princeton Global Asset Management LLC lifted its position in Synopsys by 481.8% during the second quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock valued at $33,000 after purchasing an additional 53 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its position in Synopsys by 441.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock valued at $28,000 after purchasing an additional 53 shares during the last quarter. Finally, AlphaQuest LLC grew its stake in Synopsys by 423.1% in the 2nd quarter. AlphaQuest LLC now owns 68 shares of the semiconductor company’s stock worth $35,000 after buying an additional 55 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CFO Shelagh Glaser sold 3,655 shares of the firm’s stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the transaction, the chief financial officer directly owned 15,317 shares in the company, valued at $9,339,847.09. This trade represents a 19.27% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of Synopsys stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total value of $4,945,385.70. Following the completion of the transaction, the chief accounting officer directly owned 20,520 shares in the company, valued at $10,278,468. This trade represents a 32.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 30,894 shares of company stock valued at $16,760,783 in the last 90 days. 0.62% of the stock is owned by insiders.

Synopsys Price Performance

Shares of NASDAQ:SNPS opened at $390.24 on Tuesday. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52. The stock has a market cap of $72.49 billion, a PE ratio of 30.63, a PEG ratio of 5.02 and a beta of 1.10. The company’s fifty day moving average is $450.59 and its 200 day moving average is $513.13. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.75 by ($1.45). The business had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.77 billion. Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The business’s quarterly revenue was up 14.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $3.43 earnings per share. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Research analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on SNPS. BNP Paribas began coverage on shares of Synopsys in a research report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price objective on the stock. KeyCorp reduced their target price on Synopsys from $660.00 to $590.00 and set an “overweight” rating on the stock in a research note on Wednesday, September 10th. The Goldman Sachs Group lowered their price target on Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Wells Fargo & Company dropped their price target on Synopsys from $630.00 to $550.00 and set an “equal weight” rating for the company in a research note on Wednesday, September 10th. Finally, Citigroup lowered Synopsys from a “neutral” rating to an “underperform” rating in a research report on Wednesday, September 10th. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, Synopsys has a consensus rating of “Hold” and an average target price of $562.14.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.